• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3431 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aclidinium bromide (Tudorza Genuair - Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aripiprazole for pregnant women: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Golimumab (Simponi - Janssen Inc.) new indication: ulcerative colitis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Stereotactic ablative radiation therapy for the treatment of non-small cell lung cancer]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-aortic balloon pumps for cardiac conditions: guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital Breast Tomosynthesis]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Effectiveness and safety of single-use protective sheaths for flexible nasopharyngolaryngoscopes]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of Fertil ProMD products in the treatment of infertility]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tocilizumab (Actemra - Hoffmann-La Roche Limited) new indication: polyarticular juvenile idiopathic arthritis
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Lung cancer: investigation, treatment and follow-up algorithms]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Equipment required for medication nebulization: safety and guidelines
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: an evidence-based analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: a budget impact analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Mobile apps for improving health: clinical evidence
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra - Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014     Health Quality Ontario (HQO) Hemoglobin A1c testing in diabetes: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Closed intensive care units: clinical and cost-effectiveness, safety, and guidelines
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cleaning wipes for prevention of C. difficile infection in the hospital setting: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal bacteriotherapy for adult patients with recurrent clostridium difficile infection: update of clinical, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antibacterial sutures for wound closure after surgery: update on clinical effectiveness and guidelines for use
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Population-based colorectal cancer screening: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal photopheresis following bone marrow transplant: clinical effectiveness
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-surgical surveillance for surgical site infections: guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral nutrition intake for the prevention of falls in older adults: clinical effectiveness and guidelines
2014     Health Quality Ontario (HQO) Arthroscopic debridement of the knee: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2014     Health Quality Ontario (HQO) End-of-life health care in Ontario: OHTAC recommendation
2014     Medical Advisory Secretariat (MAS) Multiple intravenous infusions
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2014     Health Quality Ontario (HQO) Arthroscopic debridement of the knee: an evidence update
2013     Health Quality Ontario (HQO) Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013     Health Quality Ontario (HQO) Transient ischemic attack: where can patients receive optimal care? A rapid review
2013     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2013     Health Quality Ontario (HQO) Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2013     Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients:a rapid review
2013     Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients: a rapid review
2013     Health Quality Ontario (HQO) Coronary revascularization in ischemic heart failure patients: a rapid review
2013     Health Quality Ontario (HQO) The effectiveness of statins for primary prevention: a rapid review
2013     Health Quality Ontario (HQO) Effectiveness of increased intensity of rehabilitation in post-stroke patients: a rapid review
2013     Health Quality Ontario (HQO) Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2013     Health Quality Ontario (HQO) Nerve blocks for pain management in patients with hip fractures: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing of hip fracture surgery: a rapid review
2013     Health Quality Ontario (HQO) Intramedullary nails in comparison with sliding hip screws for intertrochanteric hip fractures: a rapid review
2013     Health Quality Ontario (HQO) Intensity of rehabilitation after hip fracture: a rapid review
2013     Health Quality Ontario (HQO) Community versus inpatient rehabilitation in hip fracture patients: a rapid review
2013     Health Quality Ontario (HQO) Clinical utility of echocardiography for patients with hip fracture: a rapid review
2013     Health Quality Ontario (HQO) Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: a rapid review
2013     Health Quality Ontario (HQO) Periodic health examinations: a rapid economic analysis
2013     Health Quality Ontario (HQO) Antibiotic coverage in atypical pathogens for adults hospitalized with community-acquired pneumonia: a rapid review
2013     Institute of Health Economics (IHE) Stingray catheter and guidewire for recanalization of coronary chronic total occlusions: a rapid evidence assessment
2013     Health Quality Ontario (HQO) Monotherapy versus combination therapy for adults hospitalized for community-acquired pneumonia: a rapid review
2013     Institute of Health Economics (IHE) Transcutaneous bilirubinometry for the screening of neonatal hyperbilirubinemia ≥35 weeks' gestation
2013     Health Quality Ontario (HQO) Optimal timing for antibiotic administration in patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Usefulness of urinary antigen testing for Legionella in the treatment of community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Role of screening for respiratory syncytial virus or influenza and empirical antiviral treatment for patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Criteria for switching from intravenous to oral antibiotics in patients hospitalized with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Local infiltration analgesia in hip and knee arthroplasty: a rapid review
2013     Health Quality Ontario (HQO) Anesthesia among patients undergoing knee arthroplasty: a rapid review
2013     Health Quality Ontario (HQO) Intensity of rehabilitation during the acute hospitalization period after hip or knee arthroplasty: a rapid review
2013     Health Quality Ontario (HQO) Simultaneous or staged bilateral knee arthroplasty: a rapid review
2013     Health Quality Ontario (HQO) Antibiotic-laden bone cement for primary knee arthroplasty: a rapid review
2013     Health Quality Ontario (HQO) The effectiveness of cement in primary hip replacements: a rapid review
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2013     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for the treatment of aortic valve stenosis: an evidence update
2013     Health Quality Ontario (HQO) OHTAC recommendation: transcatheter aortic valve implantation for treatment of aortic valve stenosis
2013     Health Quality Ontario (HQO) Photoselective vaporization for the treatment of benign prostatic hyperplasia